fig2
![Coenzyme Q10, Vitamin E and Polyvitamin B: an exploratory double-blind randomized cross-over study in Phelan-McDermid Syndrome](https://image.oaes.cc/c519aaf9-eef6-40f0-87b4-be13bf81843b/202308.fig.2.jpg)
Figure 2. CONSORT flow-chart. Sixty-six PMS patients were assessed for eligibility. Thirty-five of them were recruited and randomized into groups receiving either active compound (n = 18) or active comparator (n = 17) during the first 4 months. Thirty-three patients completed the entire study, whereas one patient dropped out of each treatment group during the first 4-month period.